On September 27, 2025, AICARM will bring the Course for Expert Patients in Cardiomyopathy to Ragusa: free training, testimonials, resuscitation for family members, and the presentation of the book Il Cuore Grande.
From book to film: A Big Heart, the first documentary film on cardiomyopathy promoted by AICARM, tells four stories of courage. Presented at the 2025 Giffoni Film Festival, it is available on TV and streaming.
Tuscany passed the first law in Italy to prevent sudden cardiac death in young people: screening in schools, resuscitation courses, and a dedicated regional registry. This historic step was also supported by AICARM.
Dr. Andrea Pedemonte, a sports medicine specialist, has achieved an exceptional sporting feat to raise funds for AICARM and environmental causes. Starting with a 20-meter dive off the coast of Genoa, he cycled 222 km to Gressoney, then skied to the Margherita Hut on Monte Rosa, at an altitude of 4.556 meters. This gesture of solidarity combines medicine, sport, and civic engagement.
A Safe Summer with Cardiomyopathy: A webinar on practical tips for a peaceful holiday. Travel, heat, medications, and nutrition: Dr. Niccolò Maurizi and patient expert Francesca Musso offer helpful tips for facing the summer with greater awareness and well-being. Presented by Dr. Niccolò Maurizi with Francesca Musso and Maria Serena Asso. A practical and concrete meeting, the last before the summer break, [...]
The shortage of essential drugs is no longer an episodic problem, but a systemic reality that severely affects the most vulnerable patients. The Italian Association for Cardiomyopathies (AICARM) is today at the forefront in denouncing a situation that goes beyond the pharmacological emergency: the prolonged unavailability of Rhythmodan (disopyramide), a key drug for the treatment of hypertrophic obstructive cardiomyopathy.
The Italian Association for Cardiomyopathies (AICARM) expresses its strong concern about the continuing shortage of the drug Ritmodan, widely used by patients with success as a therapy for hypertrophic obstructive cardiomyopathy.
Ritmodan Shortage: The Situation is Improving, but Specific Procedures Are Still Needed Update for Patients AIFA - AICARM Press Release - June 2025 GOOD NEWS: AIFA has informed us that, contrary to initial forecasts, stocks of Ritmodan 100 and Ritmodan Retard 250 are not exhausted according to what was communicated by Avas Pharmaceuticals (distributor for Italy). The situation is improving with the arrival of new batches, expected in the [...]
AICARM APS (Associazione italiana cardiomiopatie) is a growing reality, with a solid project and a constant commitment to improving the quality of life of patients with cardiomyopathy, the main purpose of the association. The excellent state of health of the Association was confirmed by the Annual Assembly held on May 7, 2025 and approved the budget unanimously.
May is a special month for AICARM: we dedicate it to better understanding the benefits of nutrition in cardiomyopathy. However, we will not do it alone, but accompanied by one of the major international experts in this field, namely Dr. Sara Farnetti, with whom we will be able to discuss in the webinar on May 21st. Absolutely not to be missed.
